SH2B3 and cardiac hypertrophy: Further studies have demonstrated that cardiac-specific SH2B3 overexpression exacerbates pressure overload, leading to cardiac hypertrophy, fibrosis, and dysfunction by activating focal adhesion kinase, which subsequently triggers the downstream phosphoinositide 3-kinase-AKT-target of Programmed Death-1 (PD-1).